Journal
JOURNAL OF THE AMERICAN HEART ASSOCIATION
Volume 9, Issue 10, Pages -Publisher
WILEY
DOI: 10.1161/JAHA.120.015772
Keywords
coronary artery disease; coronary CT angiography; fractional flow reserve; plaque; statin
Categories
Funding
- National Natural Science Foundation of China [81671678]
- Medical Guidance Scientific Research Support Project of Shanghai Science and Technology Commission [19411965100]
- Shanghai Key Discipline of Medical Imaging [2017ZZ02005]
- Innovative Research Team of High-Level Local Universities in Shanghai
Ask authors/readers for more resources
BACKGROUND: Whether statin treatment can improve hemodynamic status of coronary atherosclerotic plaque remains unknown. It is of clinical interest to explore the hemodynamic change of coronary lesions after statin treatment. METHODS AND RESULTS: Consecutive patients with intermediate pre-test probability of coronary artery disease were prospectively enrolled and underwent baseline coronary computed tomography angiography (CCTA) as well as follow-up CCTA. The primary end point was to determine the lesion-specific change of (Delta)computed tomography-derived fractional flow reserve (Delta CT-FFR, defined as the change of CT-FFR value across each lesion) after rosuvastatin treatment. The secondary end point was to compare the change of other plaque characteristics according to serial CCTA findings. 152 patients (mean age: 67.1 +/- 9.7 years, 100 men, mean follow-up duration of 13.9 +/- 2.5 months) were finally included. In non-calcified plaque subgroup, Delta CT-FFR was significantly lower at follow-up compared with baseline (0.051 +/- 0.010 versus 0.035 +/- 0.012, P=0.013). All other parameters were not found to be significantly different between baseline and follow-up CCTA measurements. In calcified plaque and mixed plaque subgroups, all parameters showed no significant differences between baseline and follow-up CCTA groups (P>0.05 for all). According to multivariate regression analysis, non-calcified plaque was >2 times more likely than calcified plaque to observe the decrease of.CT-FFR (adjusted hazard ratio: 2.05 [1.03-4.09], P=0.042). CONCLUSIONS: In patients with mild to intermediate coronary stenosis, rosuvastatin treatment resulted in a reduction in lesion-specific Delta CT-FFR at mid-term follow-up. This hemodynamic improvement was mainly observed for non-calcified lesions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available